SGRY

Surgery Partners Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth 4/10
  • Value 3/10
Surgery Partners sales and earnings growth
SGRY Growth
Neutral
  • Revenue Y/Y 5.38%
  • EPS Y/Y 61.44%
  • FCF Y/Y 39.34%
Surgery Partners gross and profit margin trends
SGRY Profitability
Neutral
  • Gross margin 22.80%
  • EPS margin -2.30%
  • ROIC 5Y 3.53%
Surgery Partners net debt vs free cash flow
SGRY Risk
Good
  • Debt / Equity 1.3
  • Debt / FCF 15.2
  • Interest coverage 0.8

Surgery Partners stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Medical Care Facilities stocks